Continuous infusion versus intermittent dosing of ceftazidime/avibactam in critically ill patients with Klebsiella pneumoniae OXA-48 or Pseudomonas aeruginosa infections: a single-center randomized open-label trial (ZAVICONT). Rationale and design. - Momčilović M; Šitum I; Erceg A; Siroglavić M; Lovrić M; Nižić Nodilo L; Hafner A; Lovrić J; Turčić P; Fabijanović D; Marinić A; Nedeljković V; et al. (Frontiers in pharmacology, 2025)